Anti-cancer effect of GV1001 for prostate cancer: function as a ligand of GnRHR
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Ji Won | - |
dc.contributor.author | Yadav, Dharmendra K. | - |
dc.contributor.author | Kim, Soo Jin | - |
dc.contributor.author | Lee, Moo-Yeol | - |
dc.contributor.author | Park, Jung-Min | - |
dc.contributor.author | Kim, Bum Seok | - |
dc.contributor.author | Kim, Mi-hyun | - |
dc.contributor.author | Park, Hyeung-geun | - |
dc.contributor.author | Kang, Keon Wook | - |
dc.date.available | 2020-02-27T04:41:56Z | - |
dc.date.created | 2020-02-05 | - |
dc.date.issued | 2019-02 | - |
dc.identifier.issn | 1351-0088 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/1889 | - |
dc.description.abstract | GV1001, a 16-amino acid fragment of the human telomerase reverse transcriptase catalytic subunit (hTERT), has been developed as an injectable formulation of cancer vaccine. Here, we revealed for the first time that GV1001 is a novel ligand for gonadotropin-releasing hormone receptor (GnRHR). The docking prediction for GV1001 against GnRHR showed high binding affinity. Binding of GV1001 to GnRHR stimulated the G alpha s-coupled cAMP signaling pathway and antagonized G alpha q-coupled Ca2+ release by leuprolide acetate (LA), a GnRHR agonist. Repeated injection of GV1001 attenuated both serum testosterone level and seminal vesicle weight via desensitization of hypothalamicpituitary-gonadal (HPG) axis. We then tested whether GV1001 has an inhibitory effect on tumor growth of LNCaP cells, androgen receptor-positive human prostate cancer (PCa) cells. GV1001 significantly inhibited tumor growth and induced apoptosis in LNCaP-implanted xenografts. Interestingly, mRNA expressions of matrix metalloproteinase 2 and matrix metalloproteinase 9 were suppressed by GV1001, but not by LA. Moreover, GV1001 significantly inhibited the proliferation and migration of PCa cells and induced apoptosis in a concentration-dependent manner. Our findings suggest that GV1001 functions as a biased GnRHR ligand to selectively stimulate the G alpha s/cAMP pathway, with anti-proliferative and anti-migratory effects on human PCa. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | BIOSCIENTIFICA LTD | - |
dc.relation.isPartOf | ENDOCRINE-RELATED CANCER | - |
dc.subject | GONADOTROPIN-RELEASING-HORMONE | - |
dc.subject | TELOMERASE PEPTIDE VACCINATION | - |
dc.subject | OPEN-LABEL | - |
dc.subject | PANCREATIC-CANCER | - |
dc.subject | PHASE-I/II | - |
dc.subject | CELL-LINE | - |
dc.subject | APOPTOSIS | - |
dc.subject | AGONIST | - |
dc.subject | DEGARELIX | - |
dc.subject | ANALOGS | - |
dc.title | Anti-cancer effect of GV1001 for prostate cancer: function as a ligand of GnRHR | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000456738400008 | - |
dc.identifier.doi | 10.1530/ERC-18-0454 | - |
dc.identifier.bibliographicCitation | ENDOCRINE-RELATED CANCER, v.26, no.2, pp.147 - 162 | - |
dc.identifier.scopusid | 2-s2.0-85059898459 | - |
dc.citation.endPage | 162 | - |
dc.citation.startPage | 147 | - |
dc.citation.title | ENDOCRINE-RELATED CANCER | - |
dc.citation.volume | 26 | - |
dc.citation.number | 2 | - |
dc.contributor.affiliatedAuthor | Yadav, Dharmendra K. | - |
dc.contributor.affiliatedAuthor | Kim, Mi-hyun | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | GV1001 | - |
dc.subject.keywordAuthor | GnRH | - |
dc.subject.keywordAuthor | prostate cancer | - |
dc.subject.keywordAuthor | hTERT | - |
dc.subject.keywordAuthor | cancer vaccine | - |
dc.subject.keywordPlus | GONADOTROPIN-RELEASING-HORMONE | - |
dc.subject.keywordPlus | TELOMERASE PEPTIDE VACCINATION | - |
dc.subject.keywordPlus | OPEN-LABEL | - |
dc.subject.keywordPlus | PANCREATIC-CANCER | - |
dc.subject.keywordPlus | PHASE-I/II | - |
dc.subject.keywordPlus | CELL-LINE | - |
dc.subject.keywordPlus | APOPTOSIS | - |
dc.subject.keywordPlus | AGONIST | - |
dc.subject.keywordPlus | DEGARELIX | - |
dc.subject.keywordPlus | ANALOGS | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Endocrinology & Metabolism | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Endocrinology & Metabolism | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.